Form 4 holding
CEO, Interim CFO, Director, 10%+ Owner
BIOREGENX, INC.
- Security class
- Common
- Shares / value
- 197,864,944
- Estimated value
- Report date
- 08 Mar 2024
- Price
- Ownership
- Trustee of Wilshire Holdings Trust
William Resides
Insider Reports History
- Reporting-owner location
- Ringgold, TN
- Latest reporting-owner signature
-
William Resides
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for William Resides
Form 4 holding
CEO, Interim CFO, Director, 10%+ Owner
BIOREGENX, INC.
- Security class
- Common
- Shares / value
- 20,674,000
- Estimated value
- Report date
- 08 Mar 2024
- Price
- Ownership
- Direct
Form 4 holding
CEO, Interim CFO, Director, 10%+ Owner
BIOREGENX, INC.
- Security class
- Series A Preferred
- Shares / value
- 1,008
- Estimated value
- Report date
- 08 Mar 2024
- Price
- Ownership
- Trustee of Wilshire Holdings Trust
Form 4 holding
CEO, Interim CFO, Director, 10%+ Owner
BIOREGENX, INC.
- Security class
- Series A Preferred
- Shares / value
- 112
- Estimated value
- Report date
- 08 Mar 2024
- Price
- Ownership
- Direct
Insider Reports Filed by William Resides
3
BRGX
BIOREGENX, INC.
- Report period
- 08 Mar 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 22 May 2024, 13:12
- Role
- CEO, Interim CFO, Director, 10%+ Owner
- Next action
- Open filing details